Abstract
To study the transfer of oxidized phospholipids from cell membranes to high-density lipoproteins (HDL), human Cu2+-oxidized erythrocyte membranes were incubated with HDL3 subfraction for 17 h at 37°C followed by isolation of the supernatant, precipitation from it of HDL3, and determination of lipid peroxide products (LPP) in them. The incubation increased the content of lipid hydroperoxides in HDL3 significantly (by 32 and 40% calculated per ml of sample or mg of protein) and of malondialdehyde (by 27 and 34%, respectively) compared to control (incubation of HDL3 alone). The content of conjugated dienes did not change significantly. Fluorescence analyses of isolated HDL3 particles showed that the content of fluorescent products (λex = 365 nm, λem = 430 nm) in them was 2.5 times higher than in control, and the number of binding sites for the 1-anilinonaphthalene-8-sulfonic acid probe decreased by 22%. This also confirms accumulation of LPP in the lipoprotein subfraction. It seems likely that an increase in LPP (at least hydroperoxides) in HDL3 after their incubation with oxidized membranes occurs via transport of phospholipids containing LPP from erythrocyte membranes to lipoproteins. The data on the ability of HDL3 to accept LPP from erythrocyte membranes in vitro suggest that HDL3 may have a protective action on cell membranes undergoing oxidation in vivo as well.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
REFERENCES
Klimov, A. N., Kozhemyakin, L. A., Pleskov, V. M., and Andreeva, L. I. (1987) Byul. Eksp. Biol. Med. , 103, 550–552.
Mackness, M. I., and Durrington, P. N. (1995) Atherosclerosis, 115, 243–253.
Klimov, A. N., Nikiforova, A. A., Pleskov, V. M., Kuzmin, A. A., Kalashnikova, N. M., and Antipova T. O. (1989) Biokhimiya, 54, 118–123.
Vohl, M.-C., Neville, T. A.-M., Kumarathasan, R., Braschi, S., and Sparks, D. L. (1999) Biochemistry, 38, 5976–5981.
Klimov, A. N., Gurevich, V. S., Nikiforova, A. A., Shatilina, L. V., Kuzmin, A. A., Plavinsky, S. L., and Teryukova, N. P. (1993) Atherosclerosis, 100, 13–18.
Nikiforova, A. A., Kuzmin, A. A., and Klimov, A. N. (1995) Phys. Chem. Biol. Med., 2, 127–133.
Klimov, A. N., Gurevich, V. S., Nikiforova, A. A., Denisenko, A. D., Kuznetsov, A. S., Shatilina, L. V., and Plavinsky, S. L. (1994) Atherosclerosis, 109, 37–38.
Hayek, T., Oiknine, J., Danker, G., Brook, J. G., and Aviram, M. (1995) Eur. J. Clin. Chem. Clin. Biochem ., 33, 721–725.
Itabe, H., Hosoya, R., Karasawa, K., Jimi, S., Saku, K., Takebayashi, S., Imanaka, T., and Takano, T. (1999) J. Biochem. (Tokyo), 126, 153–161.
Klimov, A. N., Nikiforova, A. A., Kuzmin, A. A., Kuznetsov, A. S., and Mackness, M. I. (1998) in Advances in Lipoprotein and Atherosclerosis Research, Diagnostics and Treatment, Gustav Fischer Verlag, Jena, pp. 78–82.
Jonas, A., Hesterberg, L. K., and Drengler, S. M. (1978) Biochim. Biophys. Acta, 528, 47–57.
Miller, N. E., La Ville, A. L., and Crook, D. (1985) Nature, 314, 109–111.
Akkus, I., Saglam, N. J., Caglaya, O., Viral, H., Kalak, S., and Saglam, M. (1996) Clin. Chim. Acta, 244, 173–180.
Santos-Silva, A., Castro, E. M. B., Teixeira, N. A., Guerra, F. C., and Quintanilha, A. (1995) Atherosclerosis, 116, 199–209.
Dodge, J. T., Mitchell, C., and Hanahan, D. J. (1963) Arch. Biochem. Biophys ., 100, 119–130.
Havel, R. J., Eder, H. A., and Bragdon, J. H. (1955) J. Clin. Invest ., 34, 1345–1353.
Burstein, M., Scholnick, H. R., and Morein, R. (1970) J. Lipid Res ., 11, 583–595.
Magracheva, E. Ya. (1973) Vopr. Med. Khim., 19, 652–655.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem ., 191, 265–275.
Folch, J., Lees, M., and Sloane-Stanley, G. H. (1957) J. Biol. Chem., 226, 497–509.
Buege, J. A., and Aust, S. O. (1978) Meth. Enzymol ., 52, 302–310.
Darrow, R. A., and Organisciak, D. T. (1994) Lipids, 29, 591–594.
Smith, J. B., Ingerman, C. M., and Silver, M. I. (1976) J. Lab. Clin. Med ., 88, 169–179.
Shimasaki, H., Sato, J., and Hara, I. (1975) J. Jap. Chem. Soc ., 24, 464–468.
Formazjuk, V. E., Osis, Ju. G., Deev, A. I., Lankin, V. Z., Vihert, A. M., and Vladimirov, Ju. A. (1982) Dokl. AN SSSR, 263, 497–500.
Damen, J., Regts, J., and Scherphof, G. (1981) Biochim. Biophys. Acta, 665, 538–545.
Reed, C. F. (1968) J. Clin. Invest., 47, 749–760.
Bowry, V. W., Stanley, K., and Stocker, R. (1992) Proc. Natl. Acad. Sci. USA, 89, 10316–10320.
Maziere, J.-C., Myara, I., Salmon, S., Auclair, M., Haigle, J., Santus, R., and Maziére, C. (1993) Atherosclerosis, 104, 213–219.
Dobretsov, T. E. (1989) Fluorescence Probes in Investigation of Cells, Membranes, and Lipoproteins [in Russian], Nauka, Moscow.
Vladimirov, G. E., Pelishenko, I. A., and Urinson, A. P. (1948) Biokhimiya, 13, 449–452.
Nagata, Y., Yamamoto, Y., and Niki, E. (1996) Arch. Biochem. Biophys., 329, 24–36.
Subramanian, V. S., Goyal, J., Miwa, M., Sugatami, J., Akiyama, M., Liu, M., and Subbaiah, P. V. (1999) Biochim. Biophys. Acta, 1439, 95–109.
Christison, J., Karjalainen, A., Brauman, J., Bygrave, F., and Stocker, R. (1996) Biochem. J ., 314, 739–742.
Sattler, W., and Stocker, R. (1993) Biochem. J., 294, 771–778.
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., and Krieger, M. (1996) Science, 271, 518–520.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klimov, A.N., Kozhevnikova, K.A., Kuzmin, A.A. et al. On the Ability of High Density Lipoproteins to Remove Phospholipid Peroxidation Products from Erythrocyte Membranes. Biochemistry (Moscow) 66, 300–304 (2001). https://doi.org/10.1023/A:1010203930470
Issue Date:
DOI: https://doi.org/10.1023/A:1010203930470